Sparshmart Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
as on 23-10-2024
- Paid Up Capital ₹ 1.73 M
as on 23-10-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 15.08 Cr
as on 23-10-2024
- Satisfied Charges ₹ 3.00 Cr
as on 23-10-2024
- Revenue -18.61%
(FY 2023)
- Profit -12.04%
(FY 2023)
- Ebitda 79.14%
(FY 2023)
- Net Worth 2.45%
(FY 2023)
- Total Assets -0.72%
(FY 2023)
About Sparshmart Pharmaceuticals
The Corporate was formerly known as Sparsh Career Network Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 1.73 M.
The company currently has active open charges totaling ₹15.08 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tripti Goel and Basant Goel serve as directors at the Company.
- CIN/LLPIN
U51909DL2007PTC163921
- Company No.
163921
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sparshmart Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tripti Goel  | Director | 06-Nov-2020 | Current |
| Basant Goel | Director | 07-Aug-2008 | Current |
Financial Performance of Sparshmart Pharmaceuticals.
Sparshmart Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.61% decrease. The company also saw a substantial fall in profitability, with a 12.04% decrease in profit. The company's net worth moved up by a moderate rise of 2.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sparshmart Pharmaceuticals?
In 2023, Sparshmart Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ant Pharmacueticals Private LimitedActive 8 years 1 monthTripti Goel and Basant Goel are mutual person
Charges (Loans)
₹150.76 M
₹30.00 M
Charges Breakdown by Lending Institutions
- Others : 11.48 Cr
- Axis Bank Limited : 3.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2024 | Axis Bank Limited | ₹3.60 Cr | Open |
| 14 Aug 2020 | Others | ₹1.48 Cr | Open |
| 27 Aug 2014 | Others | ₹10.00 Cr | Open |
| 05 Jan 2013 | Vijaya Bank | ₹3.00 Cr | Satisfied |
How Many Employees Work at Sparshmart Pharmaceuticals?
Unlock and access historical data on people associated with Sparshmart Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sparshmart Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sparshmart Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
